Institutional Sign In

Go

Merck Czech Republic - Profitability

ROCE & ROE
Pharmaceutical | Czechia | April 2, 2020
$2.99
Excel Sheet

Merck Czech Republic made a net profit of CZK 50.5 mil in 2017, up 21.7% compared to the previous year. Historically, between 2002 and 2017, the company's net profit reached a high of CZK 68.6 mil in 2015 and a low of CZK 1.98 mil in 2008.

The result implies a return on equity of 7.79% and a return on invested capital of 7.18% in 2017. That is compared to an average of 10.6% and 8.69% over the last five years.

The company has been operating with average EBITDA margin of 3.67% in the last 5 years and an average net margin of 2.46%.

Since 2012, the firm's net profit increased by -20.3% or an average of -4.44% a year.

You can see all the company’s data at Merck Czech Republic profile, or you can download a report on the company in the report section.